Mounjaro Dosing Schedule: Complete Titration Guide from 2.5 mg to 15 mg

If you've been prescribed Mounjaro® (tirzepatide) or are researching it, understanding the Mounjaro dosing schedule is essential. Tirzepatide uses a gradual titration approach — starting at the lowest dose and increasing over time — to help your body adjust while minimizing side effects.

This guide walks through each dose level, explains why titration matters, and covers what to discuss with your licensed provider about finding your optimal maintenance dose.

Why Tirzepatide Uses a Titration Schedule

Titration — the process of gradually increasing medication doses — serves several important purposes with tirzepatide:

Minimizing gastrointestinal side effects: The most common side effects (nausea, diarrhea, constipation) are closely related to how quickly GLP-1 and GIP receptor activity increases. A gradual approach gives the digestive system time to adapt.

Finding the right maintenance dose: Not every patient needs the maximum dose. Some individuals achieve their treatment goals at 5 mg, 7.5 mg, or 10 mg. Titration allows providers to identify the dose that offers the best balance of efficacy and tolerability for each patient.

Safety monitoring: Gradual dose increases allow providers to monitor blood sugar levels, kidney function, and other health markers at each stage, adjusting the plan if any concerns arise.

The Complete Mounjaro Dosing Schedule

The standard tirzepatide titration schedule follows this progression. Each dose is administered as a once-weekly subcutaneous injection:

Starting dose — 2.5 mg (Weeks 1–4): This is the introductory dose designed to acclimate your body to tirzepatide. It is not a therapeutic dose for weight management or blood sugar control — its sole purpose is to reduce the likelihood of GI side effects when moving to higher doses. Most patients tolerate this dose well.

Second dose — 5 mg (Weeks 5–8): The first therapeutic dose level. Many patients begin to notice reduced appetite and early weight changes at this point. This is also the first dose at which some patients experience noticeable GI side effects as receptor activation increases.

Third dose — 7.5 mg (Weeks 9–12): This intermediate dose provides additional efficacy. Some patients find this to be their optimal maintenance dose if they're achieving good results with manageable side effects.

Fourth dose — 10 mg (Weeks 13–16): A significant step up in receptor activation. Patients who tolerate this dose well often see continued improvements in appetite control and metabolic markers.

Fifth dose — 12.5 mg (Weeks 17–20): The second-highest dose. Your provider may recommend staying at this level if you're seeing strong results without needing the maximum dose.

Maximum dose — 15 mg (Week 21+): The highest approved dose of tirzepatide. Not all patients need to reach this level, and your provider will make this determination based on your individual response and tolerability.

What to Expect at Each Dose Level

At 2.5 mg: Subtle appetite changes. Some patients notice slightly reduced hunger but no dramatic shifts. Minimal side effects for most people. This is the adjustment phase.

At 5 mg: More noticeable appetite reduction. Food portions may naturally decrease. Some patients experience mild nausea, particularly in the first few days after increasing. Weight changes may begin to appear on the scale.

At 7.5–10 mg: Significant appetite control for many patients. Cravings often decrease substantially. GI side effects from the dose increase typically settle within 1–2 weeks. Measurable weight changes are common by this stage.

At 12.5–15 mg: Maximum receptor activation. Appetite suppression is typically quite pronounced. Some patients report that the "food noise" — constant thoughts about eating — becomes very quiet. GI side effects from the final increase usually resolve with time.

Tips for a Smooth Titration Experience

These practical strategies can help minimize discomfort during dose increases:

Keep a symptom journal: Track how you feel in the days following each injection, including appetite levels, GI symptoms, energy, and mood. This information helps your provider make informed dosing decisions.

Eat mindfully during increases: In the 2–3 days following a dose increase, favor bland, easy-to-digest foods. Avoid large, heavy meals, and eat slowly to give your body time to signal fullness.

Hydrate consistently: Aim for at least 64 ounces of water daily. Dehydration exacerbates nausea and constipation — two of the most common side effects.

Don't skip the 2.5 mg phase: Even though 2.5 mg isn't a therapeutic dose, this introductory period is clinically important. Skipping it increases the risk of more severe side effects at higher doses.

Communicate with your provider: If side effects are significantly impacting your quality of life at any dose, your provider may recommend extending the time at that dose before increasing, or may determine that your current dose is your optimal maintenance level.

Frequently Asked Questions About Mounjaro Dosing

Can I stay at a lower dose if it's working? Absolutely. Your provider may recommend maintaining a dose below 15 mg if you're achieving your treatment goals with good tolerability. The goal is to find the lowest effective dose for each patient.

What if I miss a dose? If fewer than 4 days have passed since the missed dose, take it as soon as possible. If more than 4 days have passed, skip the missed dose and take the next dose on schedule. Do not take two doses to make up for a missed one. Always consult your provider for specific guidance.

Can the dose be decreased after reaching a higher level? Yes. If side effects become problematic at a higher dose, your provider may step the dose back down. This is a normal part of finding the right treatment approach.

How long does the full titration take? The standard titration from 2.5 mg to 15 mg takes approximately 20 weeks (about 5 months). However, your provider may modify this timeline based on your individual response.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.